Actively Recruiting
Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home
Led by Necmettin Erbakan University · Updated on 2024-11-22
74
Participants Needed
1
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacerbations represent a significant public health problem that places a high burden on patients, their families and society. In frequent and severe exacerbations, patients may experience a decrease in quality of life, depression, and even death up to one year after hospitalization. Costs associated with COPD are more than $15.5 billion, and hospitalizations and repeated hospital admissions related to acute exacerbations alone account for 70% of all costs. For these reasons, efforts to reduce hospital admissions and hospitalizations associated with recurrent exacerbations are imperative to improve patient's quality of life and reduce the societal burden.
CONDITIONS
Official Title
Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with stage 4 (group D) COPD according to GOLD criteria
- Aged 18 years or older
- Owns a video computer, tablet, or phone
- Has internet access at home or on the phone
- Lives in the city centre of Konya
- No communication problems preventing participation, such as inability to understand or speak Turkish
- Literate
- Uses an oxygen concentrator at home
You will not qualify if you...
- Illiterate
- Diagnosed with stage 1, 2, or 3 COPD according to GOLD criteria
- Has another lung disease besides COPD (e.g., lung cancer, asthma)
- Has physical and/or mental disabilities
- Visually and/or hearing impaired
- Communication problems preventing participation, such as inability to understand or speak Turkish
- Diagnosed with or previously had Covid-19
- Has a psychiatric disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Selçuk Tıp Fakültesi Hastanesi
Konya, Turkey (Türkiye)
Actively Recruiting
Research Team
H
HASAN BAKIR
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here